The global burden of aortic stenosis

JJ Thaden, VT Nkomo, M Enriquez-Sarano - Progress in cardiovascular …, 2014 - Elsevier
Degenerative, calcific valvular aortic stenosis (AS), caused by an active process of
atherosclerosis, calcification and ossification, is the most common cause of AS in …

Medical treatment of aortic stenosis

G Marquis-Gravel, B Redfors, MB Leon, P Genereux - Circulation, 2016 - Am Heart Assoc
Untreated, severe, symptomatic aortic stenosis is associated with a dismal prognosis. The
only treatment shown to improve survival is aortic valve replacement; however, before …

Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis

MR Dweck, S Joshi, T Murigu, F Alpendurada… - Journal of the American …, 2011 - jacc.org
Objectives: The goal of this study was to assess the prognostic significance of midwall and
infarct patterns of late gadolinium enhancement (LGE) in aortic stenosis. Background …

The ACE gene and human performance: 12 years on

Z Puthucheary, JRA Skipworth, J Rawal, M Loosemore… - Sports medicine, 2011 - Springer
Some 12 years ago, a polymorphism of the angiotensin I-converting enzyme (ACE) gene
became the first genetic element shown to impact substantially on human physical …

[HTML][HTML] Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance

MR Dweck, S Joshi, T Murigu, A Gulati… - Journal of …, 2012 - Elsevier
Background Cardiovascular magnetic resonance (CMR) is the gold standard non-invasive
method for determining left ventricular (LV) mass and volume but has not been used …

Left ventricular hypertrophy in aortic valve stenosis: preventive or promotive of systolic dysfunction and heart failure?

M Kupari, H Turto, J Lommi - European heart journal, 2005 - academic.oup.com
Aims In aortic stenosis (AS), left ventricular (LV) hypertrophy is considered a compensatory
response helping maintain systolic function. Recent research in experimental AS suggests …

Impact of valve prosthesis-patient mismatch on left ventricular mass regression following aortic valve replacement

G Tasca, F Brunelli, M Cirillo, M DallaTomba… - The Annals of thoracic …, 2005 - Elsevier
BACKGROUND: Valve prosthesis-patient mismatch is a frequent problem in patients
undergoing aortic valve replacement and its main hemodynamic consequence is to …

Myocardial stress and hypertrophy: a complex interface between biophysics and cardiac remodeling

W Grossman, WJ Paulus - The Journal of clinical …, 2013 - Am Soc Clin Investig
Pressure and volume overload results in concentric and eccentric hypertrophy of cardiac
ventricular chambers with, respectively, parallel and series replication of sarcomeres. These …

[HTML][HTML] Late hemodynamic and clinical outcomes of aortic valve replacement with the Carpentier-Edwards Perimount pericardial bioprosthesis

G Dellgren, TE David, E Raanani, S Armstrong… - The Journal of thoracic …, 2002 - Elsevier
Objectives: The aim of this study was to investigate the long-term clinical and hemodynamic
outcomes after aortic valve replacement with the Carpentier-Edwards Perimount …

Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study …

JR Ortlepp, HP Vosberg, S Reith, F Ohme, NG Mahon… - Heart, 2002 - heart.bmj.com
Background: Hypertrophic cardiomyopathy (HCM) is an inherited disease of the sarcomere
characterised clinically by myocardial hypertrophy and its consequences. Phenotypic …